Assiut University
Asyut, AssiutU, Egypt
Location status: Recruiting
NCT Number: NCT06081881
to detect the incidence of CTEPH patients.
Primary outcome To predict CETHP in symptomatic patients after pulmonary embolism episode.
Secondary outcome:
On Echocardiography revealed RV dysfunction which are peak TR Velocity , the RV/LV basal diameter ratio, flattening of the IVS, RV acceleration time and/or midsystolic notching, IVC diameter with decreased inspiratory collapse and RA area.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Asyut, AssiutU, Egypt
Location status: Recruiting
Chronic thrombo embolic pulmonary hypertension(CTEPH)is a progressive pulmonary vascular disease characterized by chronic obstruction of major pulmonary arteries with flow-limiting organized thrombi. In the clinical classification of the 6thWorld Symposium on Pulmonary Hypertension, CTEPH/chronic thromboembolic pulmonary disease(CTED)are in group4, labeled as PH due to pulmonary artery obstruction. CTEPH should be considered in PE patients if:(1)they report symptoms that could be related to CTEPH or with frank right heart failure,(2)the CTPA used to diagnose acute PE shows signs indicative of CTEPH,(3)they have risk factors or predisposing conditions for CTEPH. Recurrent venous thromboembolism(VTE),post-thrombotic syndrome, bleeding ,and functional limitations as important outcome measures of acute PE treatment , Dyspnea ,anxiety, chest pain ,post-thrombotic panic syndrome, and depression that lead to persistent functional limitations and/or decreased quality of life have been labeled as post-PE syndrome(PPS),includes CTEPH. Early diagnosis of CTEPH is important ,as it is the only form of PH that is potentially curable , but also challenging because signs of right heart failure only become evident in advanced disease stages and earlier disease stages are characterized by non specific or even absence of symptoms. The diagnostic work up of suspected CTEPH ,starts with trans thoracic Doppler echocardiography, In addition to the peak tricuspid regurgitation velocity , the right ventricle/left ventricle basal diameter ratio, flattening of the interventricular septum, right ventricular acceleration time and/or mid systolic notching, inferior vena cava diameter with decreased inspiratory collapse and right atrial area are used echocardiographic signs to assess the probability of PH.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Any patient diagnosed as acute pulmonary embolism ,aged between 18-80 years old which Pulmonary Embolism Severity Index (PESI) class III-V or sPESI ≥1,
Exclusion criteria
Secondary causes for pulmonary hypertension Severe kidney injury(eGFR>30 mg/dl/1.7m2) Hepatic affection Contraindication to anti-coagulation
Time frame: 3 years
Incidence of CTEHP in symptomatic patients after pulmonary embolism episode.
Time frame: 3 years
Measure of RV dysfunction by Echocardiography
Contact information is provided by the study sponsor or research team.
Aly M Tohamy, Professor
CONTACT
Ester A Faried, resident
CONTACT
Ester Ashraf Faried Beshay
Other
Predictors for Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism Episode
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05843500
Chronic Thromboembolic Disease, Chronic Thromboembolic Pulmonary Hypertension
San Francisco, California, United States
View Trial DetailsNCT06286891
Chronic Thromboembolic Pulmonary Hypertension, Fragility
São Paulo, Brazil
View Trial DetailsNCT06038630
Acute Pulmonary Embolism, Anemia
Durham, North Carolina, United States
View Trial DetailsNCT07272798
Chronic Thromboembolic Pulmonary Hypertension
Damascus, Rif-dimashq Governorate, Syria
View Trial Details